-
-
-
-
-
-
-
Gandeeva and Zymeworks partner on cryo-EM antibody structure work
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME)
-
-
-
-
-
-
-
Zymeworks (ZYME) Misses Q4 EPS by 55c
-
-
-
-
-
-
-
Wells Fargo Upgrades Zymeworks (ZYME) to Overweight
-
-
-
-
-
-
-
Zymeworks shifts strategy to focus on royalty-driven growth model
-
-
-
-
-
-
-
B.Riley Starts Zymeworks (ZYME) at Buy
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Zymeworks (ZYME)
-
433,938 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

